Log in to save to my catalogue

Chinese guideline on the application of anti-seizure medications in the perioperative period of supr...

Chinese guideline on the application of anti-seizure medications in the perioperative period of supr...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f8e3ca577be4671a059a8dc2e54618e

Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery

About this item

Full title

Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery

Publisher

London, England: SAGE Publications

Journal title

Therapeutic Advances in Neurological Disorders, 2022, Vol.15, p.17562864221114357-17562864221114357

Language

English

Formats

Publication information

Publisher

London, England: SAGE Publications

More information

Scope and Contents

Contents

Seizures are a common symptom of craniocerebral diseases, and epilepsy is one of the comorbidities of craniocerebral diseases. However, how to rationally use anti-seizure medications (ASMs) in the perioperative period of craniocerebral surgery to control or avoid seizures and reduce their associated harm is a problem. The China Association Against...

Alternative Titles

Full title

Chinese guideline on the application of anti-seizure medications in the perioperative period of supratentorial craniocerebral surgery

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_7f8e3ca577be4671a059a8dc2e54618e

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_7f8e3ca577be4671a059a8dc2e54618e

Other Identifiers

ISSN

1756-2864,1756-2856

E-ISSN

1756-2864

DOI

10.1177/17562864221114357

How to access this item